Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip A Harris

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 27, 2008
The identification of pyrazolo[1,5-a]pyridines as potent p38 kinase inhibitorsMui Cheung, Philip A Harris, Jennifer G Badiang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 14, 2014
Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient miceScott B Berger, Viera Kasparcova, Sandy Hoffman, et al.
Journal of Medicinal Chemistry|March 4, 2005
Discovery and evaluation of 2-anilino-5-aryloxazoles as a novel class of VEGFR2 kinase inhibitorsPhilip A Harris, Mui Cheung, Robert N Hunter, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2015
High throughput screening identifies ATP-competitive inhibitors of the NLRP1 inflammasomePhilip A Harris, Chaya Duraiswami, Donald T Fisher, et al.
Pharmacology Research & Perspectives|December 12, 2017
Identification of an antibody-based immunoassay for measuring direct target binding of RIPK1 inhibitors in cells and tissuesJoshua N Finger, Jean-Marie Brusq, Nino Campobasso, et al.
Cellular and Molecular Gastroenterology and Hepatology|October 14, 2019
RIPK1 Mediates TNF-Induced Intestinal Crypt Apoptosis During Chronic NF-κB ActivationJerry Wong, Ricard Garcia-Carbonell, Matija Zelic, et al.
The Journal of Experimental Medicine|November 2, 2017
Autophagy protein ATG16L1 prevents necroptosis in the intestinal epitheliumYu Matsuzawa-Ishimoto, Yusuke Shono, Luis E Gomez, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2018
Elevated A20 promotes TNF-induced and RIPK1-dependent intestinal epithelial cell deathRicard Garcia-Carbonell, Jerry Wong, Ju Youn Kim, et al.
Pharmacology Research & Perspectives|December 12, 2017
Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteersKathleen Weisel, Nicola E Scott, Debra J Tompson, et al.
Molecular Cell|January 2, 2019
RIPK1 and Caspase-8 Ensure Chromosome Stability Independently of Their Role in Cell Death and InflammationGianmaria Liccardi, Laura Ramos Garcia, Tencho Tenev, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|September 27, 2008
The identification of pyrazolo[1,5-a]pyridines as potent p38 kinase inhibitorsMui Cheung, Philip A Harris, Jennifer G Badiang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 14, 2014
Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient miceScott B Berger, Viera Kasparcova, Sandy Hoffman, et al.
Journal of Medicinal Chemistry|March 4, 2005
Discovery and evaluation of 2-anilino-5-aryloxazoles as a novel class of VEGFR2 kinase inhibitorsPhilip A Harris, Mui Cheung, Robert N Hunter, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2015
High throughput screening identifies ATP-competitive inhibitors of the NLRP1 inflammasomePhilip A Harris, Chaya Duraiswami, Donald T Fisher, et al.
Pharmacology Research & Perspectives|December 12, 2017
Identification of an antibody-based immunoassay for measuring direct target binding of RIPK1 inhibitors in cells and tissuesJoshua N Finger, Jean-Marie Brusq, Nino Campobasso, et al.
Cellular and Molecular Gastroenterology and Hepatology|October 14, 2019
RIPK1 Mediates TNF-Induced Intestinal Crypt Apoptosis During Chronic NF-κB ActivationJerry Wong, Ricard Garcia-Carbonell, Matija Zelic, et al.
The Journal of Experimental Medicine|November 2, 2017
Autophagy protein ATG16L1 prevents necroptosis in the intestinal epitheliumYu Matsuzawa-Ishimoto, Yusuke Shono, Luis E Gomez, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2018
Elevated A20 promotes TNF-induced and RIPK1-dependent intestinal epithelial cell deathRicard Garcia-Carbonell, Jerry Wong, Ju Youn Kim, et al.
Pharmacology Research & Perspectives|December 12, 2017
Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteersKathleen Weisel, Nicola E Scott, Debra J Tompson, et al.
Molecular Cell|January 2, 2019
RIPK1 and Caspase-8 Ensure Chromosome Stability Independently of Their Role in Cell Death and InflammationGianmaria Liccardi, Laura Ramos Garcia, Tencho Tenev, et al.
Pageof 3